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ABSTRACT 
Objective: Comparison of effectiveness of two drugs (Shiva Guggulu and Simhanada Guggulu in the same dose of both drug given separately in two different groupA and Group B) on patients of Amavata. 
Methods: Patients between 18-60 y of age with classical features of Amavata [9] from OPD and IPD of Government autonomous Ayurvedic College and Hospital were selected for the present work; irrespective of their sex, religion, education, etc. Detailed research Performa was prepared to incorporate all the signs and symptoms of the disease Amavata is the second most common joint disorders. Nowadays erroneous dietary habits, lifestyle and environment have led to various autoimmune disorders i.e. Amavisajanya Vikaara and Amavata is one among them. Rheumatoid arthritis can be correlated with Amavata in view of its clinical features. Many research studies have been done to solve this clinical enigma, but an effective, safe, less complicated treatment is still required for the management of Amavata. In the present study, 24 patients of Amavata were registered and randomly grouped into two. In group A, Shiva Guggulu 6 g/day in divided doses and in group B, Simhanada Guggulu 6 g/day in divided doses were given for 8 w. On analysis of the results, it was found that Simhanada Guggulu provided better results as compared to Shiva 
Guggulu in the management of Amavata. In group A, the mean score of grip strength was 1.14 before treatment, which was reduced to 0.57 after treatment, with 50% relief. It was statistically insignificant. The mean score of grip strength in group B was 2.4 before treatment, which was reduced to 1.5 after treatment, with 37.5% relief. It was statistically highly significant. 
Results: Before treatment the mean score of walking time in group A was 2, which was reduced to 1 after treatment, with 50% relief. It was statistically insignificant. The mean score of walking time in group B was 1.75 before treatment, which was reduced to 0.75 after treatment, with 45.71% relief. It was statistically significant. In group A, the mean score of foot pressure was 1 before treatment, which was decreased to 0.66 after treatment, with 33.33% relief. It was statistically insignificant. The mean score of foot pressure in group B was 2.3 before treatment, which was decreased to 1.4 after treatment with, 39.13% relief. It was statistically highly significant. In group A, the mean score of general functional capacity was 1.33 before treatment, which was reduced to 0.66 after treatment, with 50% relief. It was statistically highly significant. The mean score of general functional capacity in group B was 1.66 before treatment, which was reduced to 0.66 after treatment, with 60% relief and was statistically insignificant. In group A, the mean score of the degree of disease activity was 1.75 before treatment, which was reduced to 1 after treatment, with 42.85% relief. It was statistically highly significant. The mean score of the degree of disease activity in group B was 1.5 before treatment, which was reduced to 0.75 after treatment, with 50% relief. It was statistically significant. Regarding ESR value, the mean scores before treatment in A and B groups were 54.5 and 55.2, respectively, and they were reduced to 45.3 and 40.1, respectively, after treatment. Group A percentage relief was 16.88%, while in group B it was 27.35%. An apparent difference in improvement of all the cardinal symptoms was observed with the treatment. On comparing Group B proved to be better than Group A. Statistically highly significant difference was found in the improvement of Sandhigraha and statistically significant difference was found in the improvement of Sandhishoola and Sparshasahyata by Simhanada Guggulu than Shiva Guggulu, whereas insignificant difference was observed in the improvement of Sandhishotha. So, from the obtained data it may be inferred that group B is more effective than groupA. 
Conclusion: It was observed from the treatment that Simhanada Guggulu provided comparatively better relief in cardinal signs and symptoms of 
Amavata. 
Keywords: Agni, Ama, Amavata, Rheumatoid arthritis, Shiva Guggulu, Simhanada Guggulu © 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)  
INTRODUCTION Amavata (Rheumatoid Arthritis) is a challenge to the physician owing to its chronicity, incurability, complications, morbidity and crippling nature. The word Amavata is made up of a combination of two words, Ama and Vata. [1] The disease is mainly due to derangement of Agni, resulting in the production of Ama which circulates in the body and gets located in the Sandhis (joints) causing pain, stiffness, and swelling over the joints. [2] According to modern medicine, it can be correlated with Rheumatoid Arthritis (RA), [3] 
which is a chronic autoimmune disease that causes inflammation and deformity of the joints. RA can also cause inflammation of the tissues around the joints as well as other organs in the body. It is a common disorder, with varied clinical signs and symptoms related to multiple anatomical sites, both articular and extra-articular. Allopathic system of medicine has got an important role to play in overcoming symptoms of articular diseases. Drugs [4] are available to ameliorate the symptoms due to inflammation, in the form of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and the long-term 
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suppression is achieved by the Disease-Modifying Antirheumatic Drugs (DMARDs). [5] But most of the NSAIDs [6] have gastrointestinal side effects, whereas DMARDs have marrow, renal, and hepatic suppression. Hence, the management of this disease is merely insufficient in other systems of medicine and patients are continuously looking with hope towards Ayurveda to overcome this challenge. Many research works have been done to solve this clinical enigma, but an effective, safe, less complicated treatment is still required in the management of Amavata. In this clinical study, two drugs Shiva Guggulu [7] and Simhanada Guggulu [8] have been attempted to evaluate their comparative efficacy in Amavata. 
MATERIALS AND METHODS 
Selection criteria Patients between 18-60 y of age with classical features of Amavata [9] from OPD and IPD of Government autonomous Ayurvedic College and Hospital were selected for the present work; irrespective of their sex, religion, education, etc. Detailed research Performa was prepared to incorporate all the signs and symptoms of the disease. 
Inclusion criteria The criteria laid down by American Rheumatism Association (ARA)-1988 [10] were also taken into consideration as follows:  1. Morning stiffness lasting for>1 h, 2. Arthritis of three or more joints 3. Arthritis of hand joints 4. Symmetrical arthritis 5. Presence of rheumatoid nodules 6. Presence of rheumatoid factor (RA factor) 7. Radiological changes. *First four criteria must be present for the duration of 6 w or more. **Diagnosis of RA is made with four or more criteria. 
Exclusion criteria 1. Chronicity for more than 10 y 2. Having severe crippling deformity 3. Patients are suffering from cardiac disease, pulmonary TB, Diabetes Mellitus, etc. 
Investigations For the purpose of assessing the general condition of the patient and to exclude other pathologies, the following investigations were carried out. 1. RA factor. 2. Haematological investigations: The routine haematological examination was carried out which included total leukocyte count, differential count, haemoglobin, packed cell volume, and Erythrocyte Sedimentation Rate (ESR). 3. Urine analysis: Routine urine analysis was carried out to detect the involvement of kidneys and to exclude the urinary tract infections and conditions like gonorrhoea. 
Follow-up Follow-up study was carried out for 8 w after completion of treatment. 
Dietary restrictions The patients were strictly advised to follow dietary restrictions and changes in lifestyle. 
Criteria for assessment The results of the therapy were assessed on the basis of clinical signs and symptoms mentioned in Ayurvedic classics as well as by ARA 
(1988). Functional capacity was also assessed, and laboratory investigations were repeated at the end of the treatment. The scoring pattern adopted for the assessment is as follows:  
Assessment criteria The assessment criteria is shown in 
Subjective criteria Scoring 
1-Pain  No Pain 0 Mild Pain 1 Moderate Pain 2 Severe Pain 3 
2-Burning sensation  No Burning sensation 0 Mild Burning sensation 1 Moderate Burning sensation 2 Severe Burning sensation 3 
3-Malaise  No Malaise 0 Mild Malaise 1 Moderate Malaise 2 Severe Malaise 3 
Objective Criteria Scoring 
4-Tenderness  No Tenderness 0 Patients complain of pain 1 Patients complain of pain and winces 2 Patients complain of pain and withdraw 3 
5-Oedema  No swelling 0 Mild swelling 1 Moderate swelling 2 Gross swelling 3 
6-Local colour changes in skin  No colour changes 0 Mild colour changes 1 Moderate colour changes 2 Severe colour changes 3 
7-Walking Abilities  Walk easily 0 With mild difficulty 1 With moderate difficulty 2 With mark difficulty 3 Impossible 4 8-Peripheral Pulses  Absent 0 Feeble 1 Less Volume 2 Full Bounding 3 
9-Stiffness of joint  No Stiffness 0 Stiffness lasting from 5 minutes to 2 h 1 Stiffness lasting from 2 h to 8 h 2 Stiffness lasting from more than 8 h 3 
10-Warmth of jont–  Raise temperature when comparison to normal body surface. 0 Fall in local warmth 1 Normal temperature 2 No change after treatment 3 General symtoms of Amavata like Aruchi Agnimandhya Apaka Angamard Trisna Gaurava Alasya Jwara Praseka Daha Anaha Bahumutrata Vivandha Antrakujan and Daurbalya were record as mention below. Symtoms observed before treatment 2 Symtoms relief after treatment 1 Complete relief after treatment 0 No improvement after treatment 2 
11. Daha and Srotodusti  Symptoms observed before treatment 2 Improvement in symptoms 1 Absence of symptoms after treatment 0 No changes 2 
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Functional assessment The following periodical functional tests were carried out for objective assessment of the improvement of Àmavata patients. 
1. Walking time: The patients were asked to walk a distance of 25 feet and the time taken was recorded before and after the treatment by using stopwatch. 
2. Grip strength: To find out the functional capacity of the affected upper limb, the patient's ability to compress an inflated ordinary sphygmomanometer cuff under standard conditions was recorded before and after the treatment. 
3. Foot pressure: To have an objective view of the functional capacity of the legs, foot pressure was recorded by the ability of the patients to press a weighing machine. 
4. General functional capacity Complete ability to carry on all routine duties 0 Adequate normal activity despite slight difficulty in joint movement. 1 Few activities are persisting, but patient can take care of himself. 2 Patients are totally bedridden. 3 
 
Degree of disease activity For diagnostic as well as for assessment purpose, the degree of disease activity was estimated on the basis of criteria laid down by ARA (1967).  
Table 1: ARA criteria for RA 
Grade 0 1 2 3 Fatigue No there Work full time despite fatigue Pt. must interrupt work to rest Fatigue at rest Grip strengths 200 mmHg or more 199-120 mmHg 119-70 mmHg Under 70 mmHg Haemoglobin (gm %) 12.5 or more 12.4-11 10.9-9.5 <9.5 General function All activities without difficulty Most of the activities but with difficulty. Few activities care for self. A Little self-care mainly chair and bed. Patient estimate Fine Almost well Pretty good Pretty bad Physician estimate inactive Mainly active Moderately active Severely active Foot pressure 25-21 kg 20-16 kg 15-10 kg <10 kg Walking time (25fit) 15-20 second 21-30 second 31-40 second >40 second In the criteria given above, the maximum score is 30, which represents an average of grade 3 (severely active). By dividing the total score by 10, the grade of disease is obtained and denoted by fig. from 0 to 3.  
Total effect of therapy was assessed on the basis of the criteria 
given as below Complete remission 100% relief Marked Improvement 75%-99% relief Moderate Improvement 50%-74% relief Mild Improvement 25%-49% relief Unchanged <24% relief 
 
Statistical analysis The obtained information was analyzed statistically. Paired t-test was carried out to evaluate the statistical significance of the therapy. P<0.01 is considered as significant and P<0.001 is considered as highly significant. Trial Drug and Posology: Both the trial drugs were prepared at Govt. Ayurvedic Pharmacy, Indore MP. The composition is provided at [table] and [table 3]. 
Table 2: Composition of Shiva Guggulu 
Drug Latin name Proportion 
Shiva Terminalia Chebula 1 part 
Vibhitaki Terminalia bellirica 1 part 
Amalaki Emblica offcinalis 1 part 
Erandmoolachurna Ricicus communis 4 parts 
Shuddhagandhaka - 2parts 
Rasana Pluchea lanceolata 1 part 
Vidanga Embelica ribs 1 part 
Marich Piper nigram 1 part 
Pippali Piper longum 1 part 
Dantimoola Balispermum montanum 1 part 
Jatamansi Nordostachys jatamansi 1 part 
Shundi Zinziber officinale 1 part 
Devdaru Cedrus deodara 1 part 
Shuddaguggulu Commiphora mukul 1 part 
   
 
Table 3: Composition of Simhanada Guggulu 
Drug Latin name Proportion 
Shiva Terminalia Chebula  
Shuddaguggulu Commiphora mukul 1 part 
Vibhitaki Terminalia bellirica 1 part 
Amalaki Emblica offcinalis 1 part 
Erandmoolachurna Ricicus communis 4 parts 
Shuddhagandhaka - 2parts 
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Shiva Guggulu (group A): The patients of this group were treated with Shiva Guggulu at a dose of 6 g/day for 8 w with Luke warm water. 
Simhanada Guggulu (group B): The patients of this group were treated with Simhanada Guggulu at a dose of 6 g/day for 8 w with Luke warm water. 
RESULTS AND OBSERVATION A maximum number of patients (41.66%) belonged to the age group of 41-50 y. The majority of the patients were females (91.66%), 75% patients were Hindus, and 91.66% were married. 66.66% patients were housewives, 50% were from middle class, and 33.33% were uneducated patients. Maximum numbers of patients were of Vata-
Kapha Prakriti (45.83%), Mandagni (62.5%), Madhyama Sara (54.16%), Madhyama Sattva (50%) and Madhyama Samhanana (58.33%) were found in the majority of the patients. 50% of patients had negative family history, 58% patients had a gradual onset and 37.5% patients had chronicity of 2-4 y. Most of the patients were found to be indulged in Viruddha Ahara (66.66%), Snigdha Ahara (45.83%), 
Vishamashana (62.5%), Bhojanottara Vyayama, Adhyasana (54.16%), and Diwasvapa (50%). It was observed that maximum (41.6%) patients had Atichinta, followed by 33.33% with Manodvega and 25% with Shoka as Manasika Nidana. It was observed that maximum numbers of patients (100%) have Sandhishoola followed by Sandhishotha (91.66%), 
Sparshasahyata (75%), and Sandhigraha (87.50%). Among the general symptoms, Angamarda was observed in 79.16%, Aruchi in 70.83%, 
Gaurva in 83.33%, Apaka in 62.50%, Sunata-Anganama in 54.16%, 
Alasya in 37.5%, Trishna in 41.66%, and Jwara in 37.5% of patients. Majority of the patients (83.33%) had Vibandha, and 75% had Ushnata around the joints and Anaha, followed by 70.83% with Daurbalya, 66.66% with Agnimandya, 58.33% with Nidraviparyaya, 45.83% with 
Bahumutrata, 29.16% with Daha, 25.00% had Kandu and Bhrama each, 20.83% had Kukshishula, Hridgraha, Chhardi each, while 12.5% had 
Praseka and 4.16% had Antrakujana. In majority of patients, Proximal Inter-Phalangeal (PIP) joint was involved (91.66%), followed by involvement of wrist in 83.33%, knee in 79.16%, elbow in 62.50%, hip in 58.33%, shoulder in 54.16%, ankle in 50%, neck joint in 45.83%, Distal Inter-Phalangeal (DIP) joint and Meta-Carpals (MC) each in 41.66%, inter-phalangeal joint of foods in 37.50%, and jaw in 4.16% of the patients. 
Comparative effect of Shiva Guggulu and Simhanada Guggulu on 
cardinal symptoms of Amavata Effect of therapy on Sandhishoola, Sandhishotha, Sandhigraha and Sparshasahyata with the treatment of trial drugs is provided at [table 4], [table 5], [table 6], [table 7], [table 8], [table 9], [table 10], [table 11], [table 12], [table 13], [table 14]. 
Functional assessment In group A, the mean score of grip strength was 1.14 before treatment, which was reduced to 0.57 after treatment, with 50% relief. It was statistically insignificant. The mean score of grip strength in group B was 2.4 before treatment, which was reduced to 1.5 after treatment, with 37.5% relief. It was statistically highly significant. Before treatment, the mean score of walking time in group A was 2, which was reduced to 1 after treatment, with 50% relief. It was statistically insignificant. The mean score of walking time in group B was 1.75 before treatment, which was reduced to 0.75 after treatment, with 45.71% relief. It was statistically significant. In group A, the mean score of foot pressure was 1 before treatment, which was decreased to 0.66 after treatment, with 33.33% relief. It was statistically insignificant. The mean score of foot pressure in group B was 2.3 before treatment, which was decreased to 1.4 after treatment with, 39.13% relief. It was statistically highly significant. In group A, the mean score of general functional capacity was 1.33 before treatment, which was reduced to 0.66 after treatment, with 50% relief. It was statistically highly significant. The mean score of general functional capacity in group B was 1.66 before treatment, which was reduced to 0.66 after treatment, with 60% relief and was statistically insignificant. In group A, the mean score of the degree of disease activity was 1.75 before treatment, which was reduced to 1 after treatment, with 42.85% relief. It was statistically highly significant. The mean score of the degree of disease activity in group B was 1.5 before treatment, which was reduced to 0.75 after treatment, with 50% relief. It was statistically significant. Regarding ESR value, the mean scores before treatment in A and B groups were 54.5 and 55.2, respectively, and they were reduced to 45.3 and 40.1, respectively, after treatment. Group A percentage relief was 16.88%, while in group B it was 27.35%. An apparent difference in improvement of all the cardinal symptoms was observed with the treatment. On comparing Group B proved to be better than Group A. Statistically highly significant difference was found in the improvement of Sandhigraha and statistically significant difference was found in the improvement of Sandhishoola and Sparshasahyata by Simhanada Guggulu than Shiva Guggulu, whereas insignificant difference was observed in the improvement of Sandhishotha. So, from the obtained data it may be inferred that group B is more effective than group A.  
Table 4: Effect of group A in Sandhishoola 
Cardinal features n Mean BT Mean AT % of relief x SD SE t P DIP(Lt) Rt 5 6 1.8 1.33 0.6 0.5 66.66 62.5 1.2 0.83 0.45 0.41 0.2 0.17 6 5 <0.01 <0.01 PIP(Lt) Rt 7 8 1.43 1.63 0.57 0.38 60.0 70.33 0.86 1.14 0.38 0.38 0.14 0.14 6 8 <0.001 <0.001 1 MC(Lt) Rt 4 4 2.75 2.25 1.0 1.5 63.63 33.33 1.75 0.75 0.5 0.5 0.25 0.25 7 3 <0.01 >0.05 MT(Lt) Rt 2 1 1.5 2.0 0.0 1.0 100 50 1.5 1.0 0.70 - 0.25 - 3 - <0.05  Wrist((Lt) Rt 6 6 1.0 1.0 0.17 0.17 83.33 83.33 .83 .83 0.40 0.40 0.17 0.17 5 5 <0.01 <0.01 Elbow(Lt) Rt 2 2 1.5 1.0 0.5 0.5 66.66 50 1.0 0.5 1.4 0.70 1.0 0.5 1 1 >0.05 >0.05 Shoulder(Lt) Rt 4 3 1.25 1.33 0.5 0.67 30 50 0.38 0.67 0.52 0.58 0.18 0.33 2.04 2.00 >0.05 >0.05 Ankle(Lt) Rt 6 5 1.67 1.6 0.67 0.6 60 62.5 1.0 1.0 0.00 0.71 0.0 0.32 - 3.16  >0.05 Knee(Lt) Rt 8 8 2.0 2.0 0.75 0.75 62.5 62.5 1.25 1.25 0.46 0.46 0.16 0.16 7.64 7.64 <0.001 <0.001 Hip(Lt) Rt 3 2 1.67 1.0 0.67 0.5 60 50 1.0 0.5 1.0 0.71 0.58 0.5 1.7 1.0 >0.05 >0.05 Neck(Lt) 3 1.33 0.67 50 0.67 0.58 0.33 2.0 >0.05 Jaw(Lt) 1 1.0 0.0 100 - - - - - 
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Table 5: Effect of group A in Sandhishotha table 4: Effect of group A in Sandhishoola 
Cardinal features n Mean BT Mean AT % of relief x SD SE t P DIP(Lt) Rt 5 4 1.5 1.23 0.5 0.5 66.66 60.0 1 0.75 0.63 0.5 0.25 0.25 3.87 3 <0.05 <0.05 PIP(Lt) Rt 5 5 1.6 1.6 0.6 0.6 62.25 62,25 1.00 1.00 0.70 0.0 0.31 0.0 3.16 - <0.05 - 1 MC(Lt) Rt 2 2 1.5 1.5 1.0 0.5 3.333 66.66 .5 1.0 0.70 0 0.5 0.0 1 - <0.05 - MT(Lt) Rt 2 2 2. o 1.5 1.0 0.5 100 50 1.5 1.0 0.70 - 0.25 - 3 - <0.05  Wrist((Lt) Rt 6 6 1.0 1.0 0.17 0.17 83.33 83.33 .83 .83 0.40 0.40 0.17 0.17 5 5 <0.01 <0.01 Elbow(Lt) Rt 2 2 1.5 1.0 0.5 0.5 66.66 50 1.0 0.5 1.4 0.70 1.0 0.5 1 1 >0.05 >0.05 Shoulder(Lt) Rt 4 3 1.25 1.33 0.5 0.67 30 50 0.38 0.67 0.52 0.58 0.18 0.33 2.04 2.00 >0.05 >0.05 Ankle(Lt) Rt 6 5 1.67 1.6 0.67 0.6 60 62.5 1.0 1.0 0.00 0.71 0.0 0.32 - 3.16  >0.05 Knee(Lt) Rt 8 8 1.75 2.0 0.37 0.75 78.57 66.66 1.25 1.25 0.46 0.46 0.16 0.16 7.64 7.64 <0.001 <0.001 Hip(Lt) Rt 3 4 1.67 1.75 0.67 0.5 78.57 71.42 1.0 0.5 1.0 0.71 0.58 0.5 7.51 1.0 <0.001 >0.05 Neck(Lt) 3 1.33 0.67 50 0.67 0.58 0.33 2.0 >0.05 Jaw(Lt) 1 1.0 0.0 100 - - - - - 
 
Table 6: Effect of group A in sandhigraha 
Cardinal features n Mean BT Mean AT % of relief x SD SE t P DIP(Lt) Rt 5 3 1.4 1.66 0.6 0.66 57.14 60.0 0.8 1 0.45 1 0.2 0.57 4.00 1.73 <0.05 <0.05 PIP(Lt) Rt 7 7 1.6 1.6 0.6 0.6 62.25 62,25 1.00 1.00 0.70 0.0 0.31 0.0 3.16 - <0.05 - 1 MC(Lt) Rt 2 2 1.5 1.5 1.0 0.5 3.333 66.66 .5 1.0 0.70 0 0.5 0.0 1 - <0.05 - MT(Lt) Rt 2 2 2. o 1.5 1.0 0.5 100 50 1.5 1.0 0.70 - 0.25 - 3 - <0.05  Wrist((Lt) Rt 6 6 1.0 1.0 0.17 0.17 83.33 83.33 .83 .83 0.40 0.40 0.17 0.17 5 5 <0.01 <0.01 Elbow(Lt) Rt 2 2 1.5 1.0 0.5 0.5 66.66 50 1.0 0.5 1.4 0.70 1.0 0.5 1 1 >0.05 >0.05 Shoulder(Lt) Rt 4 3 1.25 1.33 0.5 0.67 30 50 0.38 0.67 0.52 0.58 0.18 0.33 2.04 2.00 >0.05 >0.05 Ankle(Lt) Rt 6 5 1.67 1.6 0.67 0.6 60 62.5 1.0 1.0 0.00 0.71 0.0 0.32 - 3.16  >0.05 Knee(Lt) Rt 5 5 1.75 2.0 0.37 0.75 66.67 63.64 1.25 1.25 0.46 0.46 0.16 0.16 7.64 7.64 <0.001 <0.001 Hip(Lt) Rt 3 4 1.67 1.75 0.67 0.5 78.57 71.42 1.0 0.5 1.0 0.71 0.58 0.5 7.51 1.0 <0.01 >0.01 Neck(Lt) 3 1.33 0.67 50 0.67 0.58 0.33 2.0 >0.05 Jaw(Lt) 1 1.0 0.0 100 - - - - - 
 
DISCUSSION Maximum numbers of patients had involvement of Kaphavriddhi and 
Prakopa, followed by Vata Vriddhi and Prakopa, Dosha and Dushti of 
Rasavaha, Asthivaha, Majjavaha, Purishvaha and Annavaha Srotas, which is in accordance with the main Srotas involved in the Amavata 
Roga Samprapti. A maximum number of patients (41.66%) belonged to the age group of 41-50 y, which shows its predominance in middle-age group. In this stage of life, Vyadhikshmatwa gradually decreases, and accumulation of Dosha occurs, particularly Vata 
Dosha which acts as the major predisposing factor for this disease process. Thus, this age group is more prone for this disease. This data is slightly in accordance with the modern findings that the onset is most frequent during the fourth and fifth decades of life, with 80% of all patients developing the disease of age between 35 and 50 y. The majority of the patients (91.66%) were females, which clearly shows the predominance of the disease in females. Textual 
reference also reflects the predominance of rheumatoid arthritis in females. The nature of the household work especially after taking meal, which is one of the causative factors mentioned in the Ayurvedic text, may be the responsible factor of Amavata. In this present study, data show that maximum (70.83%) patients were RA negative, and 29.16% were RA positive. The presence of RA factor does not establish the diagnosis for RA, but it can be of prognostic significance because patients with high titers tend to have more severe and progressive disease with extraarticular manifestation. Regarding the joint wise relief, Simhanada Guggulu showed better results than Shiva Guggulu. In both the groups, none of the patients were found to be completely cured because of the short duration course of therapy as well as chronic nature of the disease. In group A, marked improvement in 30% and moderate improvement in 70% of patients was observed, whereas, in group B, 40% of patients showed marked improvement and moderate improvement was seen in 60%. 
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Table 7: Effect of group A in sparshasahyata 
Cardinal features n Mean BT Mean AT % of relief x SD SE t P DIP(Lt) Rt 5 10 1.4 2.3 0.6 0.8 57.14 65.22 0.8 1.5 0.45 0.71 0.2 0.22 4.00 6.71 <0.05 <0.001 PIP(Lt) Rt 7 7 1.6 1.6 0.6 0.6 62.25 62,25 1.00 1.00 0.70 0.0 0.31 0.0 3.16 - <0.05 - 1 MC(Lt) Rt 2 2 1.5 1.5 1.0 0.5 3.333 66.66 .5 1.0 0.70 0 0.5 0.0 1 - <0.05 - MT(Lt) Rt 2 2 2. o 1.5 1.0 0.5 100 50 1.5 1.0 0.70 - 0.25 - 3 - <0.05  Wrist((Lt) Rt 6 6 1.0 1.0 0.17 0.17 83.33 83.33 .83 .83 0.40 0.40 0.17 0.17 5 5 <0.01 <0.01 Elbow(Lt) Rt 2 2 1.5 1.0 0.5 0.5 66.66 50 1.0 0.5 1.4 0.70 1.0 0.5 1 1 >0.05 >0.05 Shoulder(Lt) Rt 4 3 1.25 1.33 0.5 0.67 30 50 0.38 0.67 0.52 0.58 0.18 0.33 2.04 2.00 >0.05 >0.05 Ankle(Lt) Rt 6 5 1.67 1.6 0.67 0.6 60 62.5 1.0 1.0 0.00 0.71 0.0 0.32 - 3.16  >0.05 Knee(Lt) Rt 5 5 1.75 2.0 0.37 0.75 66.67 63.64 1.25 1.25 0.46 0.46 0.16 0.16 7.64 7.64 <0.001 <0.001 Hip(Lt) Rt 3 4 1.67 1.75 0.67 0.5 78.57 71.42 1.0 0.5 1.0 0.71 0.58 0.5 7.51 1.0 <0.01 >0.01 Neck(Lt) 3 1.33 0.67 50 0.67 0.58 0.33 2.0 >0.05 Jaw(Lt) 1 1.0 0.0 100 - - - - - 
 
Table 8: Effect of group B in sandhishoola 
Cardinal features n Mean 
BT 
Mean 
AT 
% of relief x SD SE t P DIP(Lt) Rt 5 6 1.8 1.33 0.6 0.5 66.66 62.5 1.2 0.83 0.45 0.41 0.2 0.17 6 5 <0.01 <0.01 PIP(Lt) Rt 10 10 2.1 1.9 0.8 0.07 61.90 63.33 1.3 1.2 0.67 0.78 0.21 0.24 6.09 4.88 <0.001 <0.001 1 MC(Lt) Rt 4 4 2.75 2.25 1.0 1.5 63.63 33.33 1.75 0.75 0.5 0.5 0.25 0.25 7 3 <0.01 >0.05 MT(Lt) Rt 2 1 1.5 2.0 0.0 1.0 100 50 1.5 1.0 0.70 - 0.25 - 3 - <0.05  Wrist((Lt) Rt 7 7 2.14 2.14 0.85 0.85 60 60 1.28 1.28 0.48 0.48 0.18 0.18 6.9 6.9 <0.001 <0.001 Elbow(Lt) Rt 2 2 1.5 1.0 0.5 0.5 66.66 50 1.0 0.5 1.4 0.70 1.0 0.5 1 1 >0.05 >0.05 Shoulder(Lt) Rt 4 3 1.25 1.33 0.5 0.67 30 50 0.38 0.67 0.52 0.58 0.18 0.33 2.04 2.00 >0.05 >0.05 Ankle(Lt) Rt 7 7 2.28 2.14 0.71 0.57 68.75 73.33 1.57 1.57 0.53 0.53 0.20 0.20 7.77 7.77 <0.001 <0.001 Knee(Lt) Rt 8 8 2.0 2.0 0.75 0.75 62.5 62.5 1.25 1.25 0.46 0.46 0.16 0.16 7.64 7.64 <0.01 <0.01 Hip(Lt) Rt 3 2 1.67 1.0 0.67 0.5 60 50 1.0 0.5 1.0 0.71 0.58 0.5 1.7 1.0 >0.05 >0.05 Neck(Lt) 3 1.33 0.67 50 0.67 0.58 0.33 2.0 >0.05 Jaw(Lt) 1 1.0 0.0 100 - - - - - 
 
Probable mode of action of Simhanada Guggulu in Amavata Both the trial drugs have Katu, Tikta Rasa, Laghu, Ruksha Guna, 
Ushna Virya, Katu Vipaka Vedanasthapana, Deepana-Pachana, 
Rasayana and Medhya Karma hence, it has Vatakaphashamaka, 
Amapachaka, Srotoshodhaka properties which helps in breaking the pathogenesis of Amavata. Specially Tikta and Katu Rasa present in 
Simhanada Guggulu possess the antagonistic properties to that of 
Ama and Kapha which are the chief causative factors in this disease. Because of their Agnivriddhikara property, they increase digestive power, which also digests Amarasa and reduces the excessive production of Kapha and also removes the obstruction of the Srotas. Because of Ushna Virya, it also alleviates vitiated Vata. Katu Rasa helps in Agni Deepana Pachana Karma of Ushna Virya, Katu Rasa and 
Kaphahara Karma of Ruksha, Laghu Guna, and Ushna Virya 
Amadosha Pachana occurs. Lekhana Karma of Laghu Guna and Tikta 
Rasa removes the adhered Dosha from the Dushita Srotas. The Ushna properties of Simhanada Guggulu do not allow the Ama to linger at the site of pathogenesis and to create Srotorodha. It reduces 
Srotorodha and pain. It also has the antagonistic action of Sheeta and 
Ruksha Guna of Vata. Thus, it controls Ama and Vata together and minimizes the process of pathogenesis. After Srotovivronoti Karma of 
Katu Rasa and Agnideepana, Srotovishodhona Karma by Tikta Rasa, 
Lekhana action Srotosodhana occurs. This leads to the assimilation of undigested and immature Amarasa. By virtue of Shoshana and Pachana property of Katu, Tikta Rasa, and Ushna Virya, it absorbs excessive 
Dravta which leads to Samyaka Yuktamagni. Due to Ushna Virya and 
Katu Vipaka of Simhanad Guggulu, Vatashamana occurs. After Samyaka 
Yuktamagni and Vatasamana Amavata, Vyadhi shaman occurs. 
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Table 9: Effect of group B in sandhishotha 
Cardinal features n Mean 
BT 
Mean 
AT 
% of relief x SD SE t P DIP(Lt) Rt 5 4 1.5 1.23 0.5 0.5 66.66 60.0 1 0.75 0.63 0.5 0.25 0.25 3.87 3 <0.05 <0.05 PIP(Lt) Rt 9 5 1.66 1.6 0.55 0.6 66.66 62,25 1.10 1.00 0.33 0.0 0.11 0.0 10.00 - <0.001 - 1 MC(Lt) Rt 2 2 1.5 1.5 1.0 0.5 3.333 66.66 .5 1.0 0.70 0 0.5 0.0 1 - <0.05 - MT(Lt) Rt 2 2 2. o 1.5 1.0 0.5 100 50 1.5 1.0 0.70 - 0.25 - 3 - <0.05  Wrist((Lt) Rt 6 6 1.0 1.0 0.17 0.17 83.33 83.33 .83 .83 0.40 0.40 0.17 0.17 5 5 <0.01 <0.01 Elbow(Lt) Rt 2 2 1.5 1.0 0.5 0.5 66.66 50 1.0 0.5 1.4 0.70 1.0 0.5 1 1 >0.05 >0.05 Shoulder(Lt) Rt 4 3 1.25 1.33 0.5 0.67 30 50 0.38 0.67 0.52 0.58 0.18 0.33 2.04 2.00 >0.05 >0.05 Ankle(Lt) Rt 7 7 2.28 2.14 0.71 0.85 68.75 60.00 1.31 1.28 0.53 0.48 0.20 0.18 7.78 6.97 <0.001 <0.001 Knee(Lt) Rt 10 10 2.0 1.9 0.8 0.8 60.00 57.68 1.2 1.1 0.63 0.31 0.2 0.1 6.0 11.0 <0.001 <0.001 Hip(Lt) Rt 3 4 1.67 1.75 0.67 0.5 78.57 71.42 1.0 0.5 1.0 0.71 0.58 0.5 7.51 1.0 <0.001 >0.05 Neck(Lt) 3 1.33 0.67 50 0.67 0.58 0.33 2.0 >0.05 Jaw(Lt) 1 1.0 0.0 100 - - - - - 
 
Table 10: Effect of group B in sandhigraha 
Cardinal features n Mean 
BT 
Mean 
AT 
% of relief x SD SE t P DIP(Lt) Rt 5 4 1.5 1.23 0.5 0.5 66.66 60.0 1 0.75 0.63 0.5 0.25 0.25 3.87 3 <0.05 <0.05 PIP(Lt) Rt 10 10 2.0 1.9 0.8 0.7 60.00 63.15 1.2 1.2 0.42 0.42 0.13 0.13 9.0 9.0 <0.001 <0.001 - 1 MC(Lt) Rt 2 2 1.5 1.5 1.0 0.5 3.333 66.66 .5 1.0 0.70 0 0.5 0.0 1 - <0.05 - MT(Lt) Rt 2 2 2. o 1.5 1.0 0.5 100 50 1.5 1.0 0.70 - 0.25 - 3 - <0.05  Wrist((Lt) Rt 7 7 1.85 1.85 0.7 0.7 61.53 61.53 1.14 1.14 0.69 0.33 0.26 0.14 4.38 8 <0.01 <0.001 Elbow(Lt) Rt 2 2 1.5 1.0 0.5 0.5 66.66 50 1.0 0.5 1.4 0.70 1.0 0.5 1 1 >0.05 >0.05 Shoulder(Lt) Rt 4 3 1.25 1.33 0.5 0.67 30 50 0.38 0.67 0.52 0.58 0.18 0.33 2.04 2.00 >0.05 >0.05 Ankle(Lt) Rt 6 5 1.67 1.6 0.67 0.6 60 62.5 1.0 1.0 0.00 0.71 0.0 0.32 - 3.16  >0.05 Knee(Lt) Rt 10 10 2.0 2.0 0.8 0.9 60.00 55.00 1.2 1.1 0.42 0.31 0.13 0.1 9.00 11.00 <0.001 <0.001 Hip(Lt) Rt 3 4 1.67 1.75 0.67 0.5 78.57 71.42 1.0 0.5 1.0 0.71 0.58 0.5 7.51 1.0 <0.001 >0.05 Neck(Lt) 3 1.33 0.67 50 0.67 0.58 0.33 2.0 >0.05 Jaw(Lt) 1 1.0 0.0 100 - - - - - 
 
Table 11: Effect of group B in sparshashayata 
Cardinal features n Mean 
BT 
Mean 
AT 
% of relief x SD SE t P DIP(Lt) Rt 4 4 1.4 1.66 0.6 0.66 57.14 60.0 0.8 1 0.45 1 0.2 0.57 4.00 1.73 <0.05 <0.05 PIP(Lt) Rt 7 7 2.0 1.71 0.7 0.6 64.25 66,25 1.20 1.10 0.50 0.40 0.17 0.10 6.97 8 <0.001 <0.001 1 MC(Lt) Rt 2 2 1.5 1.5 1.0 0.5 3.333 66.66 .5 1.0 0.70 0 0.5 0.0 1 - <0.05 - MT(Lt) Rt 2 2 2. o 1.5 1.0 0.5 100 50 1.5 1.0 0.70 - 0.25 - 3 - <0.05  Wrist((Lt) Rt 6 6 1.0 1.0 0.17 0.17 83.33 83.33 .83 .83 0.40 0.40 0.17 0.17 5 5 <0.01 <0.01 
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Elbow(Lt) Rt 2 2 1.5 1.0 0.5 0.5 66.66 50 1.0 0.5 1.4 0.70 1.0 0.5 1 1 >0.05 >0.05 Shoulder(Lt) Rt 4 3 1.25 1.33 0.5 0.67 30 50 0.38 0.67 0.52 0.58 0.18 0.33 2.04 2.00 >0.05 >0.05 Ankle(Lt) Rt 7 6 2.17 2.33 0.7 0.8 66 64 1.4 1.5 0.53 0.51 0.20 0.22 7.07 6.70 <0.001 <0.001 Knee(Lt) Rt 9 9 1.75 2.0 0.37 0.75 66.67 63.64 1.25 1.25 0.46 0.46 0.16 0.16 7.64 7.64 <0.001 <0.001 Hip(Lt) Rt 3 4 1.67 1.75 0.67 0.5 78.57 71.42 1.0 0.5 1.0 0.71 0.58 0.5 7.51 1.0 <0.01 >0.01 Neck(Lt) 3 1.33 0.67 50 0.67 0.58 0.33 2.0 >0.05 Jaw(Lt) 1 1.0 0.0 100 - - - - - 
 
Table 12: Percentage effect of therapy on cardinal symptoms 
Symtoms Shiva Guggulu % of relief Simhanada guggulu % of relief Sandhishoola 68.53 71.23 Sandhishotha 68.35 71.0 Sandhigraha 68.11 70.87 Sparshasahyata 66.02 68.01  
Table 13: Overall effects of Shiva Guggulu and Simhanada Guggulu in patients of Amavata 
Effect Group A Group B 
No of Pt. % No of Pt. % Complete Remission(100%) 0 0 0 0 Mark improvement(76-99%) 3 30 4 40 Moderate improvement(51-75%) 7 70 6 60 Mild improvement (25-50%) 0 0 0 0 Unchanged (<25%) 0 0 0 0  
Table 14: Comparative effect of both groups in patients of Amavata (by unpaired t-test) 
Chief complaints Mean±SEM 
group A 
Mean±SEM 
group B 
% Change t P Sandhishoola 0.675±0.070 1.067±0.088 36.32↓ 3.45 <0.01 Sandhishotha 0.517±0.059 0.717±.086 27.89↓ 1.91 >0.05 Sandhigraha 0.508±0.066 0.908±0.070 44.05↓ 4.12 <0.001 Sparshasahyata 0.358±0.059 0.658±0.108 45.59↓ 2.43 <0.05 
 
CONCLUSION It was observed from the treatment that Simhanada Guggulu provided comparatively better relief in cardinal signs and symptoms of Amavata. 
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